Logotype for DocGo Inc

DocGo (DCGO) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for DocGo Inc

Q2 2024 earnings summary

2 Feb, 2026

Executive summary

  • Q2 2024 revenue reached $164.9M, up 31% year-over-year, with net income rising to $5.9M and adjusted EBITDA of $17.2M, reflecting strong operational execution and new business development momentum.

  • Mobile Health Services revenue rose 46% to $116.7M, while Transportation Services increased 6% to $48.2M, driven by government contracts and new partnerships.

  • Cash and equivalents at June 30, 2024, were $85.8M, up from $58.9M at Q1 end, with cash flow from operations exceeding $35M in Q2.

  • The company is expanding partnerships across payers, providers, hospital systems, and municipal health, with several new contracts and a two-year UK contract extension.

  • Migrant-related project wind-downs in New York are freeing resources for new growth opportunities and expected to improve margins.

Financial highlights

  • Q2 2024 total revenue: $164.9M (+31% YoY); mobile health revenue: $116.7M (+46% YoY); transportation revenue: $48.2M (+6% YoY).

  • Net income for Q2 2024 was $5.9M, up from $1.3M in Q2 2023; basic and diluted EPS were $0.06.

  • Adjusted EBITDA margin improved to 10.4% from 7.3% YoY; GAAP gross margin was 31.3% (up from 30.3%), and adjusted gross margin was 33.9% (up from 33.4%).

  • SG&A as a percentage of revenue dropped to 27.7% from 32.1% YoY, reflecting cost control and a targeted reduction in force.

  • Cash and equivalents at June 30, 2024, were $85.8M, up from $58.9M at Q1 end.

Outlook and guidance

  • 2024 revenue guidance reaffirmed at $600–$650M, with adjusted EBITDA of $65–$75M.

  • Cash flow from operations guidance raised to $80–$90M for 2024, up from $70–$80M.

  • Base business revenue expected to be $400M in 2025, excluding potential migrant-related revenues; 2025 base business projected to grow over 30% with adjusted EBITDA margin above 10%.

  • Medical transportation projected to grow 15–20% annually; mobile health segment expected to see even larger growth.

  • Mobile Health Services revenue expected to decline in H2 2024 as migrant-related projects wind down, despite new project launches.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more